<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>mrna — GZERO Media</title>
<link>https://www.gzeromedia.com/tag/mrna</link>
<description>The latest news and analysis from GZERO Media.</description>
<language>en</language>
<copyright>© GZERO Media</copyright>
<atom:link href="https://www.gzeromedia.com/feeds/tag/mrna.xml" rel="self" type="application/rss+xml" />
<lastBuildDate>Wed, 06 Aug 2025 14:50:32 +0000</lastBuildDate>
<item>
<title>Hard Numbers: Great Barrier Reef suffers worst coral damage, US cuts mRNA vaccine funding, South Korea opens visa-free tourism for Chinese visitors, &amp; More</title>
<link>https://www.gzeromedia.com/news/hard-numbers/hard-numbers-great-barrier-reef-suffers-worst-coral-damage-us-cuts-mrna-vaccine-funding-south-korea-opens-visa-free-tourism-for-chinese-visitors-more</link>
<guid isPermaLink="false">cmvrg8kzglg1i07my4l8chop4</guid>
<pubDate>Wed, 06 Aug 2025 14:50:32 +0000</pubDate>
<dc:creator>Zac Weisz, Lizzy Yee</dc:creator>
<category>robert kennedy jr</category>
<category>poland</category>
<category>climate change</category>
<category>nato</category>
<category>vaccines</category>
<category>asia</category>
<category>great barrier reef</category>
<category>china</category>
<category>mrna</category>
<category>ai</category>
<category>south korea</category>
<category>europe</category>
<category>Hard Numbers</category>
<description>39: Australia’s Great Barrier Reef – the biggest living ecosystem in the world – has suffered its largest annual coral decline since monitoring began 39 years ago.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrdgciadjbu07my4gcet1sg" type="image/jpeg" medium="image" width="4597" height="2586">
<media:credit>REUTERS</media:credit>
<media:text>A school of fish swim above a staghorn (Acropora cervicornis) coral colony as it grows on the Great Barrier Reef off the coast of Cairns, Australia October 25, 2019.</media:text>
</media:content>
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrdgciadjbu07my4gcet1sg" />
<content:encoded><![CDATA[<p><strong>39:&nbsp;</strong>Australia’s Great Barrier Reef – the biggest living ecosystem in the world – has <a rel="noopener noreferrer" target="_blank" href="https://www.bbc.com/news/articles/cvg3pp52m65o"><u>suffered</u></a> its largest annual coral decline since monitoring began 39 years ago. Tropical cyclones and coral-eating starfish are partly responsible, but experts say rising sea temperatures due to climate change are the main culprit.</p><p><strong>5:</strong> Law and Justice-backed <strong>Karol Nawrocki&nbsp;</strong>began his five-year term as Polish president after his <a rel="noopener noreferrer" target="_blank" href="https://www.reuters.com/world/europe/polands-new-president-draws-battlelines-with-government-over-constitution-2025-08-06/"><u>inauguration</u></a> earlier today. Nawrocki will be a consistent thorn in the side of centrist Prime Minister <strong>Donald Tusk</strong>: unlike Tusk, the new president supports tax cuts and doesn’t see a place for Ukraine in NATO nor the European Union.</p><p><strong>$500 million:&nbsp;</strong>US Health and Human Services Secretary <strong>Robert F. Kennedy Jr.</strong> <a rel="noopener noreferrer" target="_blank" href="https://www.washingtonpost.com/health/2025/08/05/mrna-contract-canceled-rfk-hhs/"><u>canceled</u></a> nearly $500 million in funding for mRNA vaccine research. mRNA technology, which gives genetic instructions to the body on how to fight diseases, enabled the rapid development of the COVID-19 vaccine. Several large studies say mRNA is safe, but the technology has faced scrutiny from Kennedy Jr., vaccine skeptic groups, and other members of the Trump administration.</p><p><strong>2:&nbsp;</strong>Just how big is the AI spending boom? Over the past two quarters, investment in artificial intelligence has <a rel="noopener noreferrer" target="_blank" href="https://sherwood.news/markets/the-ai-spending-boom-is-eating-the-us-economy/"><u>contributed more</u></a> to American GDP growth than consumer spending, according to Renaissance Macro, an economic research company.</p><p><strong>30:&nbsp;</strong>South Korea announced it will temporarily <a rel="noopener noreferrer" target="_blank" href="https://www.scmp.com/news/china/diplomacy/article/3320983/chinese-tourists-offered-visa-free-entry-south-korea-september"><u>allow</u></a> Chinese nationals to visit with a tour group for 30 days without needing a visa. It’s the first time that Seoul has allowed Chinese tourists to enter without a visa like this. The pilot program, which runs from Sept. 29 to June 30 next year, is part of a cautious thaw in bilateral relations.</p>]]></content:encoded>
</item>
<item>
<title>Hard Numbers: French oil refinery blockades, China’s mRNA milestone, Moscow comes to Bali, IMF tweaks rules for Ukraine, TikTok hearing</title>
<link>https://www.gzeromedia.com/news/hard-numbers-french-oil-refinery-blockades-chinas-mrna-milestone-moscow-comes-to-bali-imf-tweaks-rules-for-ukraine-tiktok-hearing</link>
<guid isPermaLink="false">cmvrf778xitjk07lqscq3lrmt</guid>
<pubDate>Wed, 22 Mar 2023 19:32:53 +0000</pubDate>
<dc:creator>Riley Callanan, Gabrielle Debinski</dc:creator>
<category>china</category>
<category>federal reserve</category>
<category>indonesia</category>
<category>australia-pacific</category>
<category>imf loans</category>
<category>gas shortage</category>
<category>interest rates</category>
<category>georgia</category>
<category>russia ukraine war</category>
<category>asia</category>
<category>mrna</category>
<category>vaccines</category>
<category>europe</category>
<category>turkey</category>
<category>middle-east</category>
<category>french pension reform</category>
<category>russia</category>
<category>immigration</category>
<category>News</category>
<description>As French protesters continue to strike and block oil refineries in response to the government’s recently passed pension reform, 13% of petrol stations around the country are running short on gas.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrbp6dwam0z07lq7tysc8q5" type="image/jpeg" medium="image" width="5857" height="3772">
<media:credit>REUTERS/Eric Gaillard</media:credit>
<media:text>Car drivers queue to fill their fuel tank at a TotalEnergies gas station in Nice as petrol supplies are disrupted by a strike of French refineries and depots, France, March 20, 2023.</media:text>
</media:content>
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrbp6dwam0z07lq7tysc8q5" />
<content:encoded><![CDATA[<p><strong>13:</strong> As French protesters continue to strike and block oil refineries in response to the government’s recently passed pension reform, <a rel="noopener noreferrer" target="_blank" href="https://www.bbc.com/news/world-europe-65037507">13%&nbsp;</a>of petrol stations around the country are running short on gas. What’s more, a lack of shipments from LNG terminals is raising fears of <a rel="noopener noreferrer" target="_blank" href="https://www.reuters.com/business/energy/shipments-stopped-totalenergies-refineries-strike-continues-2023-03-20/">shortages</a> – and elevated prices – across Europe.</p><p><strong>1:</strong> China has finally approved its <a rel="noopener noreferrer" target="_blank" href="https://www.aljazeera.com/news/2023/3/22/china-approves-first-domestic-mrna-covid-19-vaccine">first mRNA COVID vaccine</a> for emergency use. Beijing says that the drug shows high rates of protection when administered as a booster, though it provided few other details.</p><p><strong>22,000:</strong> Most Russians fleeing conscription and oppression have gone to Georgia, Armenia, and even <a rel="noopener noreferrer" target="_blank" href="https://www.npr.org/2022/10/09/1127274054/thousands-of-russians-continue-to-arrive-in-turkey-fleeing-conscription">Turkey</a>. But many have also fled to faraway … Bali. Now, Bali’s governor has asked Indonesia’s central government to rescind a rule allowing Russians and Ukrainians to apply for visas upon arrival, pointing to the fact that <a rel="noopener noreferrer" target="_blank" href="https://www.wsj.com/articles/small-moscow-emerges-in-bali-stirring-backlash-a6385b2b?mod=world_major_1_pos4">22,000 Russians</a> arrived on the island in January alone. Jakarta introduced the measure to get a post-COVID tourism bump, but some say the newcomers are ruining the island’s zen.</p><p><strong>15.6 billion:</strong> The IMF has agreed to a preliminary loan for Ukraine worth a whopping <a rel="noopener noreferrer" target="_blank" href="https://www.reuters.com/world/europe/imf-reaches-staff-agreement-with-ukraine-156-bln-program-over-four-years-sources-2023-03-21/">$15.6 billion</a>, the biggest package for Kyiv since Russia’s invasion began in Feb. 2022 – though it still needs to be approved by the board. In order to get this deal across the line, the IMF, whose main shareholder is the US, recently changed a rule to allow loans to go to countries facing “exceptionally high uncertainty.”</p><p><strong>5:&nbsp;</strong>The Federal Reserve hiked interest rates by a<a rel="noopener noreferrer" target="_blank" href="https://www.msn.com/en-us/money/other/march-fed-interest-rate-decision-due-today-after-svb-collapse-follow-for-live-updates/ar-AA18W2lc"> quarter point</a>, bringing its key short-term interest rate up to 5%. The decision signals that the Fed is continuing its campaign to temper inflation and consumer price increases, even after the recent banking turmoil.</p><p><strong>150 million:</strong> That’s how many of its users TikTok claims are US-based, according to its CEO, Shou Zi Chew. On Thursday, Sou will <a href="https://www.gzeromedia.com/news/by-ian-bremmer/should-the-us-ban-tiktok">testify</a> before a US House committee hearing to <a rel="noopener noreferrer" target="_blank" href="https://www.nytimes.com/2023/03/23/technology/tiktok-congress-hearing.html">answer questions</a> about the suspected ties of ByteDance, TikTok’s parent company, to China’s ruling Communist Party amid growing calls for a US ban.</p>]]></content:encoded>
</item>
<item>
<title>COVID vaccine rollout: Taking stock 3 years on</title>
<link>https://www.gzeromedia.com/news/covid-vaccine-rollout-taking-stock-3-years-on</link>
<guid isPermaLink="false">cmvrf6tz6isiv07lqtew73yg2</guid>
<pubDate>Thu, 09 Mar 2023 22:53:32 +0000</pubDate>
<dc:creator>Benjamin Dooley</dc:creator>
<category>world health organization</category>
<category>mrna</category>
<category>covid-19</category>
<category>covax</category>
<category>covid-19 vaccine</category>
<category>News</category>
<description>Nearly 7 million people have died worldwide, and while the virus is still out there, most countries now have access to effective jabs.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrbohmyak5r07lqb47mmp60" type="image/jpeg" medium="image" width="3250" height="2167">
<media:credit>Jui Kun Weng / SOPA Images/Sipa USA via Reuters Connect</media:credit>
<media:text>A mother holds her daughter&apos;s arm as a healthcare worker administers the child with Pfizer-BNT covid-19 vaccine in Taiwan.</media:text>
</media:content>
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrbohmyak5r07lqb47mmp60" />
<content:encoded><![CDATA[<p>It’s been almost three years since the World Health Organization declared COVID-19 a global pandemic.</p><p>Since then, we have gone from the fear of greeting one another in public to the horrors of overcrowded ERs and morgues — to the remarkably fast development of a vaccine and its uneven rollout. Nearly 7 million people have died worldwide, and while the virus is still out there, most countries now have access to effective jabs.</p><p><strong>How did we do?</strong> In mid-2020, many of us were visiting loved ones through hospital windows, spraying our grocery bags with bleach, and wondering whether public life would ever again go “back to normal.” It seemed like the horror would never end, but a break in the clouds came in Dec. 2020, with the first mRNA vaccines making their way into arms in the US and UK. (Chinese jabs were <a href="https://www.gzeromedia.com/vaccine-diplomacy-china-in-the-global-south">developed first</a> but proved less effective, and no one remembers Russia’s <a href="https://www.gzeromedia.com/putins-vaccine-gamble">miracle drug</a> that never was.)</p><p>While it seemed like a long wait, the vaccines were rolled out in record time. “We had a virus that was not known to science before December 31, 2019, and we had a vaccine in people's arms in December 2020,” says Dr. Amesh Adajla. a senior scholar at the Johns Hopkins Center for Health Security.</p><p>Prior to COVID, the fastest-ever rollout of a vaccine was for mumps, and that took nearly four years. Within 12 months, the coronavirus jab was available thanks to concentrated research. Decades of DNA research enabled scientists to being designing the mRNA for the COVID vaccine as soon as genetic code became available.</p><p>“Various scientific groups and manufacturers were able to provide enough doses to do very big studies very quickly, so we had answers super early,” says Dr. Margaret Ann Harris, an epidemiologist at the WHO. “Never in the history of humanity have we had really good data so quickly.”</p><p>Today, some 5.5 billion people around the globe – 72% of the population – have received at least one dose. But in the early months, the rollout was slow and <a href="https://www.gzeromedia.com/news/by-ian-bremmer/2021-in-review-the-year-in-world-news">uneven</a>.</p><p>Global inequities in access and high rates of <a href="https://www.gzeromedia.com/the-graphic-truth-who-s-refusing-the-covid-vaccine">vaccine hesitancy</a> made the world vulnerable to new variants. <a href="https://www.gzeromedia.com/vaccine-politics-and-human-rights">Vaccine nationalism</a> — the me-first approach to battling COVID — saw Western countries opting to inoculate their own populations before sending vaccines abroad. But, <a href="https://www.gzeromedia.com/video/gzero-world-clips/the-dangers-of-an-uneven-covid-19-vaccine-rollout">as Ian Bremmer told us then</a>, the race to outsmart COVID was (and is) global.</p><p>Health officials in early 2021 stressed the need to treat vulnerable populations around the globe first — and not only for humanitarian reasons. After all, outbreaks anywhere put <em>everyone</em> in danger of new mutations that could compromise the existing vaccines, as we’ve seen to varying degrees with both the delta and omicron variants.</p><p>The <a href="https://www.gzeromedia.com/the-covax-state-of-play">COVAX initiative</a> worked to get vaccines to the rest of the world — to date delivering nearly 2 billion doses to 146 countries — but supply issues and vaccine nationalism slowed their efforts early on. Dr. Harris says she became “the most hated person in Britain” in early 2021 for saying that the next step after vaccinating the at-risk population at home should be to send jabs to vulnerable groups abroad.</p><p><strong>So how can we do better next time?</strong> It’s perhaps no surprise that domestic politics pushed governments to cater to their own populations first.</p><p>“Politicians will always default to protectionism. The same thing happened during the 2009 H1N1 influenza pandemic when Australia developed the first vaccine and they put export restrictions on it,” says Adajla.</p><p>The only way to avoid that is to make plans now. “We must put a clear strategy in place to distribute vaccines globally, put aside what keeps individual groups happy and go for what really needs to be done for humanity,” says Harris, noting how there are still plenty of countries where under 40% are vaccinated against COVID today</p><p>A <a rel="noopener noreferrer" target="_blank" href="https://apps.who.int/gb/inb/pdf_files/inb4/A_INB4_3-en.pdf">WHO treaty</a> is in the works that lays out recommendations for pandemic-related international cooperation, preparedness, and response. We’ll be watching to see whether it can help protect us from the scourge of vaccine nationalism.</p>]]></content:encoded>
</item>
<item>
<title>After COVID vaccines, time to use mRNA tech against other infectious diseases</title>
<link>https://www.gzeromedia.com/video/gzero-live/after-covid-vaccines-time-to-use-mrna-tech-against-other-infectious-diseases</link>
<guid isPermaLink="false">cmvrevt4ehwb807lq0qeicodh</guid>
<pubDate>Sat, 12 Mar 2022 23:00:00 +0000</pubDate>
<dc:creator>GZERO Staff</dc:creator>
<category>gates foundation</category>
<category>melanie saville</category>
<category>equitable vaccine distribution</category>
<category>covid-19</category>
<category>mrna</category>
<category>science-tech</category>
<category>vaccines</category>
<category>infectious diseases</category>
<category>GZERO Live</category>
<description>Using mRNA technology to develop effective COVID vaccines has been a scientific breakthrough. But that&apos;s just the tip of the iceberg, Melanie Saville, head of vaccine development at the Coalition for Epidemic Preparedness Innovations, said during a livestream discussion on equitable vaccine distribution hosted by GZERO Media in partnership with the Bill &amp; Melinda Gates Foundation. &quot;There&apos;s still a lot that should be done with the technology moving forward&quot; on other infectious diseases like HIV, malaria, or TB. Still, she said that vaccines are only the beginning.Local manufacturing and distribution is as important — as is future equitable access to the mRNA tech itself.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrb5jwy8sl907myp1qu6gjt" type="image/jpeg" medium="image" width="1280" height="720">
<media:credit>youtu.be</media:credit>
<media:text>After COVID Vaccines, Time to Use mRNA Tech Against Other Infectious Diseases | GZERO Media</media:text>
</media:content>
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrb5jwy8sl907myp1qu6gjt" />
<content:encoded><![CDATA[<p>Using mRNA technology to develop effective COVID vaccines has been a scientific breakthrough.</p><p>But that's just the tip of the iceberg, Melanie Saville, head of vaccine development at the Coalition for Epidemic Preparedness Innovations, said during a livestream discussion on equitable vaccine distribution hosted by GZERO Media in partnership with the Bill &amp; Melinda Gates Foundation. "</p><p>There's still a lot that should be done with the technology moving forward" on other infectious diseases like HIV, malaria, or TB. Still, she said that vaccines are only the beginning.</p><p>Local manufacturing and distribution is as important — as is future equitable access to the mRNA tech itself.<br></p>]]></content:encoded>
</item>
<item>
<title>Can the world learn lessons from vaccine inequity?</title>
<link>https://www.gzeromedia.com/video/gzero-live/can-the-world-learn-lessons-from-vaccine-inequity</link>
<guid isPermaLink="false">cmvrevgqxhv1v07lq27he2rp1</guid>
<pubDate>Wed, 02 Mar 2022 23:03:58 +0000</pubDate>
<dc:creator>GZERO Staff</dc:creator>
<category>mark suzman</category>
<category>ian bremmer</category>
<category>africa</category>
<category>africa cdc</category>
<category>natasha kimani</category>
<category>covid-19 vaccine</category>
<category>healthcare</category>
<category>melanie saville</category>
<category>covid-19</category>
<category>vaccine equity</category>
<category>jose manuel barroso</category>
<category>science-tech</category>
<category>mrna</category>
<category>vaccines</category>
<category>gates foundation</category>
<category>economic recovery</category>
<category>john nkengasong</category>
<category>GZERO Live</category>
<description>GZERO Media and the Bill &amp; Melinda Gates Foundation convened leading experts in public health, research, development, and philanthropy on Thursday to discuss the uneven state of global recovery from health and economic perspectives.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrb4xxl8s2d07myb79143m1" type="image/jpeg" medium="image" width="1280" height="720">
<media:credit>youtu.be</media:credit>
<media:text>Can the World Learn Lessons From Vaccine Inequity? | Missed Shot | GZERO Media</media:text>
</media:content>
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrb4xxl8s2d07myb79143m1" />
<content:encoded><![CDATA[<p><em>GZERO Media and the Bill &amp; Melinda Gates Foundation convened leading experts in public health, research, development, and philanthropy on Thursday to discuss the uneven state of global recovery from health and economic perspectives. Participants included moderator </em><strong>Natasha Kimani</strong><em> of Africa No Filter; Eurasia Group President </em><strong>Ian Bremmer</strong><em>; </em><strong>José Manuel Barroso,</strong><em> chair of Gavi, The Vaccine Alliance; </em><strong>Dr. John Nkengasong</strong><em>, director of the Africa Centers for Disease Control; </em><strong>Melanie Saville</strong><em>, director of vaccine research and development for CEPI; and </em><strong>Mark Suzman</strong><em>, CEO of The Bill &amp; Melinda Gates Foundation.</em> <em>They discussed vaccine equity and how we can end the COVID pandemic in a way that better equips the world for similar challenges in the future.</em></p><p>On many streets in the UK and US, it’s almost possible to forget that there’s an ongoing COVID-19 pandemic. With so many westerners double vaccinated and boosted, the threat of the omicron variant has eased. In fact, the CDC just lifted mask recommendations for much of the US. But that doesn’t mean the pandemic is over. For many countries, that’s far from the case.</p><p>Moderator Natasha Kimani, the research and media programs lead at Africa No Filter, kicked off the discussion by asking where things stand today as the world marks the second anniversary of the pandemic.</p><p>“It depends on where you sit,” says Dr. John N. Nkengasong, a virologist and director of Africa’s CDC. “If you’re sitting in Africa, the glass is half empty. If you’re sitting in the global north, the glass may be half full.”</p><p>There’s a reason for optimism in parts of the world that have managed to vaccinate a majority of their populations. But in Africa, says Nkengasong, there’s deep concern because the virus, and its effects remain “very unpredictable and very unsettled.” Optimism elsewhere, he warns, should be approached with caution and humility because more surprises may await us. “There’s still a lot we need to learn about the virus,” he says.</p><p>Nkengasong is optimistic the world will overcome the pandemic but is concerned by how long it will take. “We are dealing with a very determined enemy — let there not be doubt in anyone’s mind.”</p><p>Sadly, many low-income countries are still struggling to get vaccines and distribute them properly. With only 11 percent of the African continent vaccinated, <a rel="noopener noreferrer" target="_blank" href="https://news.un.org/en/story/2022/02/1111202">according to the UN</a>, much more needs to be done.</p><p>So, why have some countries fared so well while others have languished?</p><p>“The world has not provided equitable distribution,” says Mark Suzman, CEO of The Bill &amp; Melinda Gates Foundation, which came at the cost of “lives lost that could’ve been saved.” Before a vaccine was available, countries agreed in principle to distribute a future jab to the most vulnerable. But once a vaccine was developed, Suzman explains, domestic political pressures in western countries led to a free-for-all instead.</p><p>Politics aside, the production of such a quick and effective vaccine is remarkable, and the technological innovation is worth heralding. “I think we've put 10 years of development into less than a year,” says Melanie Saville, director of vaccine research and development for CEPI.</p><p>But as for the lessons to be learned from their unequal distribution? Suzman points to two areas. First, we must finish addressing the current crisis and ensure effective delivery of vaccines to the unvaccinated. But, second, we must get ahead of future health threats by ensuring there’s enough volume of treatments available in both low- and higher-income countries. To be ready for the next pandemic, he says, we need to have all the tools and structures in place, including good surveillance, research and development, and manufacturing capabilities to respond to health threats within a couple of hundred days.</p><p>You would think that a global pandemic threatening millions of lives would pull the world together in search of a solution. Instead, we’ve witnessed political fragmentation in the US and vaccine inequity worldwide.</p><p>Russia’s invasion of Ukraine, meanwhile, has managed to take the pandemic off everyone’s radar. What’s a deadly virus compared to the threat of nuclear weapons? “Maybe we should give President Putin a Nobel prize of medicine because, apparently, he made COVID disappear,” quips Manuel Barroso, chair of Gavi, The Vaccine Alliance. Putin, of course, did nothing of the sort, and low oxygen supplies in Ukraine <a rel="noopener noreferrer" target="_blank" href="https://www.who.int/news/item/27-02-2022-dangerously-low-medical-oxygen-supplies-in-ukraine-due-to-crisis-warn-who-director-general-and-who-regional-director-for-europe">have spotlighted</a> how COVID, as well as many other medical issues, are amplified during times of war.</p><p>But the Russian assault on Ukraine has managed to breathe new life into transatlantic cooperation. Could this newfound energy for a bolstered alliance help move the needle on other issues, such as health?</p><p>“I think the answer’s yes,” says Eurasia Group President Ian Bremmer. The pandemic wasn’t enough to shake up the dysfunctions in geopolitics, he explains, pointing to the politicization of health care at home and vaccine distribution inequity worldwide.</p><p>But the idea of a western collision with a nuclear-armed Russia?</p><p>That’s enough to shake up the allies and get them moving forward together, and Bremmer expects that cooperation to be long-lasting and to extend beyond the realms of defense and security (the wildcard being China and its future relationship with Russia), which will hopefully make it easier to help end the COVID pandemic and prepare for future health crises.</p><p>Looking back at the fight against COVID, Nkengasong likens the struggle in 2020 to one of fighting “a war with bare hands.” Last year, vaccines became the main tool for fighting back. This year, he says, we need to use every tool at our disposal — including self-testing, vaccines, boosting vaccine equity worldwide, ensuring access to new drugs — to prepare for the next variant, which “might cause severe disease.”</p><p>Only then, in late 2022, does he think there’s hope for “seeing the light at the end of the tunnel.”</p>]]></content:encoded>
</item>
<item>
<title>Omicron &amp; the undoing of China&apos;s COVID strategy</title>
<link>https://www.gzeromedia.com/video/gzero-world-with-ian-bremmer/omicron-the-undoing-of-chinas-covid-strategy</link>
<guid isPermaLink="false">cmvreu1d8gxeo07myws3k7g3x</guid>
<pubDate>Mon, 17 Jan 2022 11:45:00 +0000</pubDate>
<dc:creator>GZERO Staff</dc:creator>
<category>yanzhong huang</category>
<category>covid-19 variants</category>
<category>zero covid</category>
<category>council on foreign relations</category>
<category>herd immunity</category>
<category>contact tracing</category>
<category>asia</category>
<category>mrna</category>
<category>vaccines</category>
<category>xi jinping</category>
<category>ian bremmer</category>
<category>olympics</category>
<category>china</category>
<category>politics</category>
<category>science-tech</category>
<category>GZERO World with Ian Bremmer</category>
<description>In China, Xi Jinping&apos;s zero-COVID approach faces its toughest test to date with omicron. Why? Because China lacks mRNA jabs, and so few Chinese people have gotten COVID that overall protection is very low.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrb2jko99s707lq8uemi98e" type="image/jpeg" medium="image" width="1280" height="720">
<media:credit>youtu.be</media:credit>
<media:text>Omicron and the Undoing of China’s COVID Strategy | GZERO World with Ian Bremmer</media:text>
</media:content>
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrb2jko99s707lq8uemi98e" />
<content:encoded><![CDATA[<p>Omicron is here. The bad news is that it's more contagious. The good news is that mRNA vaccines work against death and hospitalization. COVID may soon become endemic in some parts of the world.</p><p>Not in China, where Xi Jinping's zero-COVID approach faces its toughest test to date with omicron. Why? Because China lacks mRNA jabs, and so few Chinese people have gotten COVID that overall protection is very low.</p><p>Get ready for a wave of lockdowns that'll severely disrupt the world's second-largest economy — just a month out from the Beijing Winter Olympics.</p><p>That could spell disaster for Beijing, Yanzhong Huang, senior fellow for global health at the Council on Foreign Relations, tells Ian Bremmer on this week's episode of GZERO World.</p><p>Still, he says zero COVID remains popular with most Chinese people.</p><p>If things get really bad, though, Huang believes China will pivot to living with the virus, especially as the cost of keeping zero COVID in the age of omicron becomes too high. He thinks that's the right move for Xi.</p><p>Indeed, Huang expects China to start reversing course soon after the Games, and when the pandemic becomes endemic in other parts of the world. Beijing will throw in the towel on zero tolerance in 1-2 years, max.</p><p>Also, a look at vaccine incentives around the world. Do prizes like cows and brothel visits actually convince holdouts to get the jab?</p><p><em>Subscribe to </em><a rel="noopener noreferrer" target="_blank" href="https://www.youtube.com/c/GZEROMedia?sub_confirmation=1"><em>GZERO Media's YouTube channel</em></a><em> to get notifications when new episodes are published.</em></p>]]></content:encoded>
</item>
<item>
<title>What We’re Watching: No Yalta in 2022, Kazakh turmoil worsens, China needs mRNA jabs</title>
<link>https://www.gzeromedia.com/news/what-were-watching-no-yalta-in-2022-kazakh-turmoil-worsens-china-needs-mrna-jabs</link>
<guid isPermaLink="false">cmvretskehpl407lq50070e6a</guid>
<pubDate>Thu, 06 Jan 2022 18:17:48 +0000</pubDate>
<dc:creator>Carlos Santamaria, Willis Sparks</dc:creator>
<category>nato</category>
<category>asia</category>
<category>mrna</category>
<category>vaccines</category>
<category>china</category>
<category>xi jinping</category>
<category>russia</category>
<category>ukraine</category>
<category>european union</category>
<category>kazakhstan</category>
<category>josep borrell</category>
<category>europe</category>
<category>zero covid</category>
<category>News</category>
<description>EU warns the US and Russia.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrb25tn8od607my98ei39qy" type="image/jpeg" medium="image" width="5088" height="3647">
<media:credit>REUTERS</media:credit>
<media:text>L-R: Winston Churchill, Franklin D. Roosevelt and Josef Stalin with their advisers at Yalta, in the Crimea, where the Allies decided the future of post-Second World War Europe.</media:text>
</media:content>
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrb25tn8od607my98ei39qy" />
<content:encoded><![CDATA[<p><strong>EU warns the US and Russia.</strong> EU officials look to be getting nervous about meetings next week between Russia, the US, and NATO. Though NATO representatives from EU member states will be part of the talks, the EU itself was not invited to join. During a visit to Ukraine this week, the EU’s top diplomat <a rel="noopener noreferrer" target="_blank" href="https://www.ft.com/content/4fec318e-1e53-4f9a-999a-443a432dd6cd?emailId=61d6b55969d3520004d8b51b&amp;segmentId=13b7e341-ed02-2b53-e8c0-d9cb59be8b3b">warned</a> that “We are no longer in Yalta times,” a reference to the 1945 <a rel="noopener noreferrer" target="_blank" href="https://www.atlanticcouncil.org/blogs/new-atlanticist/the-yalta-conference-at-seventy-five-lessons-from-history/">Yalta agreement</a> among the US, Great Britain, and the Soviet Union that helped to divide post-war Europe into eastern and western blocs. “In this dialogue, there are not two actors alone, not just the US and Russia,” Josep Borrell added. Russia has massed 100,000 troops along its <a href="https://www.gzeromedia.com/is-putin-going-to-invade-ukraine">border with Ukraine</a>, and Vladimir Putin has demanded guarantees that NATO not expand to include Ukraine or other former Soviet states. The EU’s comments are intended, in part, to reassure Ukraine that it will not be abandoned to Russian domination. But it’s also a sign that officials in Brussels don’t fully trust US President Joe Biden to protect European rights and interests in bargaining with Putin.</p><p><strong>More Kazakh turmoil.</strong> <a rel="noopener noreferrer" target="_blank" href="https://www.nytimes.com/live/2022/01/06/world/kazakhstan-protests">Violence continues to escalate</a> in Kazakhstan, where security forces have been <a target="_blank" href="https://www.reuters.com/world/asia-pacific/kazakh-president-says-he-has-given-orders-shoot-kill-terrorists-2022-01-07/">told</a> to shoot protesters without warning, and troops from a Russian-led military alliance have arrived on the scene at the invitation of the frightened Kazakh leaders. The unrest began in the town of Zhanaozen in response to a planned price hike that immediately doubled the cost of fuel. The trouble then spread to Almaty, the country’s most populous city, and to Nur-Sultan, the capital. As we wrote <a href="https://www.gzeromedia.com/what-we-re-watching-turmoil-in-kazakhstan-macron-targets-anti-vaxxers-haiti-presidential-murder-probe">yesterday</a>, President Kassym-Jomart Tokayev has declared a state of emergency after anti-government demonstrators were killed by police during intense protests and state buildings were set aflame. Tokayev’s decisions to sack the government and <a rel="noopener noreferrer" target="_blank" href="https://www.bbc.com/news/world-asia-59896471">call off the fuel price hike</a> have not appeased protesters, who remain angry not just about inflation, but also about wealth inequality in a resource-rich country and the perceived cronyism and ineptitude of a regime that has dominated Kazakh politics since the fall of the Soviet Union. Russia is now <a rel="noopener noreferrer" target="_blank" href="https://www.theguardian.com/world/2022/jan/06/shots-heard-in-kazakhstan-as-protests-enter-third-day">directly involved</a> in restoring order. China — which imports a lot of Kazakh oil, gas, and minerals — is watching closely.</p><p><strong>China's mRNA vaccine race.</strong> China is <a rel="noopener noreferrer" target="_blank" href="https://www.ft.com/content/5213b69e-607c-4121-8668-9f9302eb390d">rushing</a> to develop homegrown mRNA vaccines, as the world's most populous and second-largest economy scrambles to contain local COVID outbreaks with the more transmissible omicron variant. Throughout the pandemic, Beijing has focused on mass-producing traditional vaccines to inoculate its population — and <a href="https://www.gzeromedia.com/vaccine-diplomacy-china-in-the-global-south">export them overseas</a> — but those jabs offer <a rel="noopener noreferrer" target="_blank" href="https://qz.com/2107603/are-sinovac-and-sinopharm-effective-against-omicron/">much less protection against omicron</a>. China has refused to license the mRNA vaccines by Pfizer and Moderna. This strategy, along with Xi Jinping's zero-COVID approach to completely isolate the population from the virus, has come at a heavy cost: our parent company Eurasia Group's <a rel="noopener noreferrer" target="_blank" href="https://www.eurasiagroup.net/live-post/top-risks-2022-1-No-zero-Covid">#1 top geopolitical risk</a> for 2022 is that a zero-COVID policy will cause many <a href="https://www.gzeromedia.com/chinas-coming-covid-crisis">problems for China</a>. Right now, only one local mRNA vaccine candidate has been approved to conduct a booster trial, so it's unlikely the country will have several effective jabs ready to go until at least a year from now. Will the urgency of omicron force Xi to risk losing face by ditching zero COVID and approving foreign-made mRNA vaccines? Don't hold your breath, nor underestimate China's capacity to get big things done at surprising speed.</p>]]></content:encoded>
</item>
<item>
<title>Omicron will be home for Christmas</title>
<link>https://www.gzeromedia.com/video/quick-take/omicron-will-be-home-for-christmas</link>
<guid isPermaLink="false">cmvret3mbgu5507myzo96xnj0</guid>
<pubDate>Mon, 13 Dec 2021 21:01:07 +0000</pubDate>
<dc:creator>GZERO Staff</dc:creator>
<category>ian bremmer</category>
<category>quick take</category>
<category>vaccine effectiveness</category>
<category>covid travel restrictions</category>
<category>covid-19 vaccine</category>
<category>covid-19 variants</category>
<category>booster shots</category>
<category>mrna</category>
<category>science-tech</category>
<category>covid-19</category>
<category>economic recovery</category>
<category>delta variant</category>
<description>Ian Bremmer&apos;s Quick Take: We are in the midst of very significant learning on the omicron variant, and I thought I would share what we know and what we really don&apos;t know, because the headlines obscure that.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrb10m68mxm07my82r2rqne" type="image/jpeg" medium="image" width="1280" height="720">
<media:credit>youtu.be</media:credit>
<media:text>Omicron Will Be Home for Christmas | Quick Take | GZERO Media</media:text>
</media:content>
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrb10m68mxm07my82r2rqne" />
<content:encoded><![CDATA[<p><strong>Ian Bremmer's Quick Take:</strong></p><p>Happy Monday, and yeah, I think I'm still talking to you about the pandemic. I was hoping I would be talking a lot less about the pandemic these days, but we are in the midst of very significant learning on the omicron variant, and I thought I would share what we know and what we really don't know, because the headlines obscure that.</p><p>What we know: Big news is that the vaccines don't work very well at all to prevent spread. And that's even true for the mRNA vaccines, the best vaccines, Pfizer and Moderna, that if you've taken two shots, which means that you're considered fully vaccinated and you've got your app, or you've got your vaccine passport, you really aren't protected from getting infected from omicron. Pfizer showing after two vaccine jabs something like 23% effectiveness, which is not effective at all. And the non-mRNA vaccines look like they're even worse, which means that a very, very transmissible strain is not being prevented by the vaccines. That's the bad news, and it's bad news.</p><p>Having said that, we know that they work really well to prevent hospitalization and death. And that's not just true for the mRNA vaccines. It's true for other vaccines too. And by the away, it's true even before you get a booster shot. In other words, if you've just gotten two shots from Pfizer, two shots from Moderna, you're really not going to get hospitalized or die from COVID. It's very, very unlikely indeed, but you are quite likely to be able to contract it and spread it, and that's a problem.</p><p>Now, we've seen a lot of headlines that say that Omicron is milder as a variant. And the reality is, we don't know that. What we know is that a lot more people are vaccinated, and we also know that the vaccinated people are particularly among those that are most vulnerable. The oldest, the people that have preexisting conditions. That is a population that is very significantly vaccinated, in some countries close to 100%, which means that the outcomes are milder than they would have been from delta, simply because omicron is hitting populations that are more protected against hospitalization and death. And that the people that aren't vaccinated are primarily people that aren't likely to get sick from COVID. Younger, healthier populations. But we don't yet have any conclusions around to what extent you are equally or more or less likely to get seriously sick if you are unvaccinated, even if you're unvaccinated and you already got COVID, than from delta. And that uncertainty is something we probably won't have real data on for at least another week or two.</p><p>And I will tell you that the epidemiologists that I've been talking to tell me that if they were to guess, they'd guess that so far, educated guess, that it's probably about the same or maybe a little milder, but not much, than delta, and that most of the change is from the change in population, as opposed to the impact of the disease.</p><p>Okay. We also know that omicron is spreading really, really fast. That it's going to be dominant in the United Kingdom and very shortly as a variant. It's already in 30 states that we know of in the US. That means it's really in every US state, and it will be the dominant spread in the United States within a few weeks. So yes, omicron will be home for Christmas. And also some good news is that vaccinations are getting pushed up. We're seeing people more quickly get vaccinated, get their boosters as a consequence of the news around omicron.</p><p>Having said all of that, the staggering level of spread even among vaccinated populations mean that hospitals could easily get overwhelmed again as a consequence of this. In the next week in the United Kingdom, that's absolutely possible. In Denmark, that's absolutely possible. And in the United States over the coming month, that's absolutely possible as well. So we are not out of the woods, and that means in terms of travel, in terms of vaccine passports, you're going to see a lot of changes.</p><p>Increasingly, if you've got two vaccines, that's not going to be seen as enough to travel internationally, which is annoying to a lot of people, because you kind of assumed that it would even a week or two ago. Now, no, not so much. And what if you've been boosted? Well, you're probably going to need another booster in six months' time. Again, in all of the apps and the vaccine passports and the papers that are allowing you to go to restaurants, and shows, and travel, in those places where those regulations exist are likely to get updated to require a booster shot, and then eventually another booster shot, too.</p><p>Madness. When does it all end? Well, it is a problem because the nature of the vaccines and the relationship with the disease make this much harder to politically respond to. In other words, the argument for getting your booster shot is not about whether or not you're going to get sick. The argument about getting the booster shot and another booster shot is about protecting people that are unvaccinated, protecting those that are immunocompromised, even if they have been vaccinated, and that's a harder argument to make. It's a harder argument for politicians to be effective at. It's a harder argument to push mandates upon a population.</p><p>And having said that, you look at the last few months, and Kaiser Family Foundation just put out a study in the United States where we're still seeing 1,000 deaths on an average day from COVID. 163,000 people did not have to die from COVID if we had gotten full vaccination rates. In other words, the science was there, the vaccines were there, and just the effectiveness of those vaccines on populations that are not immunocompromised, 163,000 people would be alive today that are not from COVID because we couldn't get our act together in getting vaccines rolled out, getting people to be willing to take them.</p><p>And that is the problem going forward. I'm not going to die from COVID. If you've been vaccinated, you're not going to die from COVID, but a lot of people will. And they will from this omicron variant, because we are unable to ramp out boosters fast enough, and second boosters fast enough, which a lot of people are sick of, a lot of people aren't going to feel comfortable with. We don't have the regulatory capacity to get it done, and that means the non-vaccinated population is going to be incredibly vulnerable and exposed. And it also means that economic impact of all of that will continue to grow, and that's around the world. That's not just the United States, that's everywhere, and that's particularly older and vulnerable populations.</p><p>So that's what we're looking at. Merry Christmas to everybody. I'm sorry. I wish I had better news on that front. I'm still hoping that over the next week or two, we get more information that will allow us to say that omicron is actually somewhat milder in form than delta is, but right now we don't have that information. The information we have is not so happy. So that's it, and I hope everyone is doing okay, and I will talk to you all real soon.</p>]]></content:encoded>
</item>
<item>
<title>Africa’s vaccine cloning gamble</title>
<link>https://www.gzeromedia.com/news/africas-vaccine-cloning-gamble</link>
<guid isPermaLink="false">cmvrerhjwhiby07lqkcrw69e5</guid>
<pubDate>Wed, 27 Oct 2021 22:20:30 +0000</pubDate>
<dc:creator>Carlos Santamaria</dc:creator>
<category>africa</category>
<category>covid-19 vaccine</category>
<category>south africa</category>
<category>pfizer</category>
<category>mrna</category>
<category>biden administration</category>
<category>moderna</category>
<category>News</category>
<description>A South African startup wants to reverse-engineer Moderna&apos;s COVID jab. That would be a huge win for the country and wider unvaxxed Africa, but don&apos;t get too excited just yet.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrayb9k8jh407mytfjso4es" type="image/jpeg" medium="image" width="1054" height="703">
<media:credit>Jess Frampton</media:credit>
</media:content>
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrayb9k8jh407mytfjso4es" />
<content:encoded><![CDATA[<p>Less than a year after the world started putting COVID vaccines into people's arms, most regions have immunized at least half their populations, but <a href="https://www.gzeromedia.com/africas-covid-crisis-and-the-politics-of-selfishness">Africa</a> still lags behind. With industrialized nations hoarding jabs and the <a href="https://www.gzeromedia.com/the-covax-state-of-play">COVAX</a> facility faltering, barely five percent of the African population is fully vaccinated.</p><p>Some enterprising South African scientists are now making a bold bid to change that, with an experiment that could benefit not only Africa's 54 nations and billion people, but the entire world: Afrigen Biologics and Vaccines, a Cape Town-based startup, has developed a plan to <a rel="noopener noreferrer" target="_blank" href="https://apnews.com/article/coronavirus-pandemic-technology-business-cape-town-health-48046e5255cc3e4fa27455fc12ab5e52">reverse-engineer</a> Moderna's mRNA shot and manufacture it for priority distribution on the continent.</p><p><strong>How are they going to do it?</strong> The ingredients in Moderna's vaccine "recipe" are mostly publicly available — the trick is to figure out what to do with them. It's like having all the ingredients and measurements to bake a cake, but only vague instructions for each step.</p><p>Given that the Moderna vaccine was developed with US taxpayer money, lawyers are still figuring out which aspects of the process belong solely to the company. But that may be moot for now: the company says it <a rel="noopener noreferrer" target="_blank" href="https://www.bloomberg.com/news/articles/2020-10-08/moderna-won-t-enforce-patents-on-covid-vaccines-during-pandemic">won't sue</a>, leaving Afrigen apparently in the clear to go ahead.</p><p><strong>Cloning an mRNA vaccine would be a huge win for South Africa.&nbsp;</strong>It would be the equivalent of the moon landing in terms of accomplishment and prestige for a nation that too often grabs headlines for all the <a href="https://www.gzeromedia.com/south-africa-rule-of-law-or-cult-of-personality">wrong reasons</a>. Moreover, the project is backed and funded by the World Health Organization, so if the code is cracked, the formula would be made available to all as a public good across the whole continent and the wider developing world.<br><br>A highly effective yet affordable jab that can be manufactured anywhere could be a game-changer to stop more contagious COVID variants from emerging where the population is still unvaccinated. What's more, the sky's the limit when it comes to <a rel="noopener noreferrer" target="_blank" href="https://www.ft.com/content/1f7f349f-d9e0-4b10-aa03-f411328f52ea">mRNA's potential</a> to create vaccines against other diseases endemic to Africa such as Ebola, less infectious but way deadlier than COVID.</p><p><strong>But don't get too excited just yet.&nbsp;</strong>The startup says it'll take up to a year to reverse-engineer Moderna's jab. Also, getting the formula right is only one piece of the puzzle. Afrigen would then need to figure out how to mass-produce, store, and deliver the vaccine around a continent with often poor infrastructure, not to mention getting raw materials at a moment when <a href="https://www.gzeromedia.com/will-biden-be-the-grinch-this-year">global supply chains</a> are already stretched thin.</p><p><strong>There's a political angle too.</strong> In the US, the Biden administration <a rel="noopener noreferrer" target="_blank" href="https://www.axios.com/covid-vaccine-moderna-biden-global-supply-covax-ff74663f-8123-40e1-bc91-f91fdbb92f4c.html?utm_campaign=organic&amp;utm_medium=socialshare&amp;utm_source=twitter">wants</a> Moderna to sell more vaccines to COVAX at cost, and is facing growing <a rel="noopener noreferrer" target="_blank" href="https://twitter.com/gregggonsalves/status/1448982781132947472">criticism</a> for treating the company with kid gloves after ignoring Biden's call to boost production for low-income countries despite Uncle Sam being Moderna's research sugar daddy.</p><p>Meanwhile, public health advocates are urging the National Institutes of Health to <em>force</em> Moderna to <a rel="noopener noreferrer" target="_blank" href="https://www.washingtonpost.com/business/2021/03/25/moderna-vaccine-patent-nih/">give up its secret sauce</a>, and calling out the US government for paying lip service to <a href="https://www.gzeromedia.com/would-you-get-rid-of-covid-19-vaccine-patents">waiving patents</a> and global vaccine equity while not pushing the drugmakers harder to share their tech or prioritize supply for countries with low vaccination rates.</p><p><strong>Technically, the Biden administration has some leverage</strong> because the White House bankrolled Moderna's vaccine research through the NIH and Operation Warp Speed. But twisting Moderna's arm would be a hard sell for the US government, traditionally reticent to meddle with Big Pharma and with little to gain (politically at home) from vaccinating other countries.</p><p>Moderna, for its part, <a rel="noopener noreferrer" target="_blank" href="https://apnews.com/article/coronavirus-pandemic-technology-business-united-nations-europe-d4aff7ddb273194b312354a57c244ce6">says</a> that right now it's better for the company to expand production itself than to <a rel="noopener noreferrer" target="_blank" href="https://www.science.org/doi/10.1126/science.abm8724">share its tech</a> because scaling up production in Africa will take too long. More broadly, it's also playing a longer game of aiming to dominate the post-COVID mRNA manufacturing landscape along with Pfizer.</p><p><strong>No one knows if reverse-engineering mRNA COVID vaccines will work, but then again no one's tried before.</strong> Still, the upshot is that there's a huge opportunity despite uncertainty about the science, the business of producing the jab, and the politics behind it all.</p>]]></content:encoded>
</item>
<item>
<title>The race to vaccinate: Dr. Atul Gawande provides perspective</title>
<link>https://www.gzeromedia.com/video/gzero-world-with-ian-bremmer/the-race-to-vaccinate</link>
<guid isPermaLink="false">cmvrekuj2gw2t07lqz4pc0mj3</guid>
<pubDate>Mon, 08 Feb 2021 12:30:00 +0000</pubDate>
<dc:creator>GZERO Staff</dc:creator>
<category>covax</category>
<category>mrna</category>
<category>johnson &amp; johnson</category>
<category>joe biden</category>
<category>covid-19</category>
<category>gzero world</category>
<category>pandemic</category>
<category>us politics</category>
<category>astrazeneca</category>
<category>vaccines</category>
<category>asia</category>
<category>ian bremmer</category>
<category>covid-19 vaccine</category>
<category>moderna</category>
<category>dr. atul gawande</category>
<category>pfizer</category>
<category>science-tech</category>
<category>israel</category>
<category>india</category>
<category>GZERO World with Ian Bremmer</category>
<description>Can the US vaccinate enough of its population to prevent hundreds of thousands of deaths before new and more contagious COVID-19 variants take hold? Surgeon and public health expert Dr. Atul Gawande, most recently of the Biden/Harris COVID-19 Transition Task Force, joins Ian Bremmer on GZERO World to discuss the latest in the global effort to vaccinate our way out of this pandemic.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvramdga8n0707lq81gotvm2" type="image/jpeg" medium="image" width="1280" height="720">
<media:credit>youtu.be</media:credit>
<media:text>The Race to Vaccinate | Biden COVID-19 Adviser, Dr. Atul Gawande | GZERO World</media:text>
</media:content>
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvramdga8n0707lq81gotvm2" />
<content:encoded><![CDATA[<p>Can the US vaccinate enough of its population to prevent hundreds of thousands of deaths before new and more contagious COVID-19 variants take hold? And will these vaccines even be effective against more adaptable mutations of the virus? Surgeon and public health expert Dr. Atul Gawande, most recently of the Biden/Harris COVID-19 Transition Task Force, joins Ian Bremmer on GZERO World to discuss the latest in the global effort to vaccinate our way out of this pandemic. He also explains why people should get the Johnson &amp; Johnson vaccine if offered the chance, despite its lower overall efficacy rate compared to the mRNA-based vaccines from Pfizer and Moderna.</p>]]></content:encoded>
</item>
<item>
<title>Podcast: The Race to Vaccinate: Dr. Atul Gawande Provides Perspective</title>
<link>https://www.gzeromedia.com/podcast/gzero-world-podcast/the-race-to-vaccinate-podcast</link>
<guid isPermaLink="false">cmvreku4ygw0t07lq6owcav5m</guid>
<pubDate>Sat, 06 Feb 2021 12:00:00 +0000</pubDate>
<dc:creator>GZERO Staff</dc:creator>
<category>podcast</category>
<category>ian bremmer</category>
<category>dr. atul gawande</category>
<category>covid-19 vaccine</category>
<category>johnson &amp; johnson</category>
<category>covid-19</category>
<category>moderna</category>
<category>pfizer</category>
<category>mrna</category>
<category>coronavirus mortality rates</category>
<category>coronavirus treatment</category>
<category>joe biden</category>
<category>us politics</category>
<category>GZERO World with Ian Bremmer Podcast</category>
<description>Listen: Can the US vaccinate enough of its population to prevent hundreds of thousands of deaths before new and more contagious COVID-19 variants take hold? Surgeon and public health expert Dr. Atul Gawande, most recently of the Biden/Harris COVID-19 Transition Task Force, joins the podcast to discuss the latest in the global effort to vaccinate our way out of this pandemic. He also explains why people should get the Johnson &amp; Johnson vaccine if offered the chance, despite its lower overall efficacy rate compared to the mRNA-based vaccines from Pfizer and Moderna.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvramda380pz07mywf6jmn47" type="image/jpeg" medium="image" width="640" height="640" />
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvramda380pz07mywf6jmn47" />
<content:encoded><![CDATA[<p><a href="https://www.gzeromedia.com/podcast/gzero-world-podcast/the-race-to-vaccinate-podcast"><strong>Transcript</strong></a></p><p><strong>Listen:</strong> Can the United States vaccinate enough of its population to prevent hundreds of thousands of deaths before new and more contagious COVID-19 variants take hold? And will these vaccines even be effective against more adaptable mutations of the virus? Surgeon and public health expert Dr. Atul Gawande, most recently of the Biden/Harris COVID-19 Transition Task Force, joins the podcast to discuss the latest in the global effort to vaccinate our way out of this pandemic. He also explains why people should get the Johnson &amp; Johnson vaccine if offered the chance, despite its lower overall efficacy rate compared to the mRNA-based vaccines from Pfizer and Moderna.</p><p><em>Subscribe to the GZERO World Podcast on </em><a rel="noopener noreferrer" target="_blank" href="https://podcasts.apple.com/us/podcast/gzero-world-with-ian-bremmer/id1294461271"><em>Apple Podcasts</em></a><em>, </em><a rel="noopener noreferrer" target="_blank" href="https://open.spotify.com/show/13QW2sLPCjVbdDE6fmJCNf"><em>Spotify</em></a><em>, </em><a rel="noopener noreferrer" target="_blank" href="https://www.stitcher.com/show/gzero-world-with-ian-bremmer"><em>Stitcher</em></a><em>, or your preferred podcast platform to receive new episodes as soon as they're published.</em></p>]]></content:encoded>
</item>
<item>
<title>A shot in the arm: Moderna’s co-founder on the COVID-19 vaccine</title>
<link>https://www.gzeromedia.com/video/gzero-world-with-ian-bremmer/a-shot-in-the-arm-the-covid-19-vaccine-arrives</link>
<guid isPermaLink="false">cmvrejoo8gs8507lqno7lt7b1</guid>
<pubDate>Mon, 14 Dec 2020 13:00:00 +0000</pubDate>
<dc:creator>GZERO Staff</dc:creator>
<category>gzero world</category>
<category>ian bremmer</category>
<category>noubar afeyan</category>
<category>moderna</category>
<category>covid-19 vaccine</category>
<category>covid-19</category>
<category>mrna</category>
<category>biotechnology</category>
<category>covid vaccine development</category>
<category>GZERO World with Ian Bremmer</category>
<description>Ian Bremmer interviews Noubar Afeyan, the co-founder of leading vaccine developer Moderna. They discuss distribution plans, the revolutionary science behind Moderna&apos;s vaccine, and how a company younger than Twitter became a frontrunner in the race to end the pandemic.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrak8s57xgk07my8iszlz9g" type="image/jpeg" medium="image" width="1280" height="720">
<media:credit>youtu.be</media:credit>
<media:text>A Shot In The Arm: The COVID-19 Vaccine Arrives | Moderna Co-Founder Noubar Afeyan | GZERO World</media:text>
</media:content>
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrak8s57xgk07my8iszlz9g" />
<content:encoded><![CDATA[<p>The pandemic's US death toll shows no signs of abating and the holiday season's spike will likely dwarf any surge that came before it. But in the midst of this dark winter there are glimmers of hope, as the first of the COVID-19 vaccines have nearly arrived (or, depending on when you read this, already have). On GZERO World, Ian Bremmer interviews Noubar Afeyan, the co-founder of a leading vaccine developer Moderna. They'll discuss distribution plans, the revolutionary science behind Moderna's vaccine, and how a company younger than Twitter became a frontrunner in the race to end the pandemic.</p>]]></content:encoded>
</item>
<item>
<title>Podcast: COVID Vaccine in Record Time - What Now? Moderna Co-Founder Noubar Afeyan</title>
<link>https://www.gzeromedia.com/podcast/gzero-world-podcast/covid-vaccine-in-record-time-what-now-podcast</link>
<guid isPermaLink="false">cmvrejnbxgs2z07lq77cs1v08</guid>
<pubDate>Sat, 12 Dec 2020 11:00:00 +0000</pubDate>
<dc:creator>GZERO Staff</dc:creator>
<category>ian bremmer</category>
<category>podcast</category>
<category>covid-19 vaccine</category>
<category>covid-19</category>
<category>pandemic</category>
<category>noubar afeyan</category>
<category>biotechnology</category>
<category>mrna</category>
<category>science-tech</category>
<category>scientific research</category>
<category>moderna</category>
<category>GZERO World with Ian Bremmer Podcast</category>
<description>Listen: The pandemic&apos;s US death toll shows no signs of abating and the holiday season&apos;s spike will likely dwarf any surge that came before it. But in the midst of this dark winter there are glimmers of hope, as the first of the COVID-19 vaccines have nearly arrived (or, depending on when you read this, already have). On the GZERO World Podcast, Ian Bremmer interviews Noubar Afeyan, the co-founder of a leading vaccine developer Moderna. They&apos;ll discuss distribution plans, the revolutionary science behind Moderna&apos;s vaccine, and how a company younger than Twitter became a frontrunner in the race to end the pandemic.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrak6cr8jcx07lql97q37pw" type="image/jpeg" medium="image" width="640" height="640" />
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrak6cr8jcx07lql97q37pw" />
<content:encoded><![CDATA[<p><a href="https://www.gzeromedia.com/podcast/gzero-world-podcast/covid-vaccine-in-record-time-what-now-podcast"><strong>Transcript</strong></a></p><p><strong>Listen:&nbsp;</strong>The pandemic's US death toll shows no signs of abating and the holiday season's spike will likely dwarf any surge that came before it. But in the midst of this dark winter there are glimmers of hope, as the first of the COVID-19 vaccines have nearly arrived (or, depending on when you read this, already have). On the GZERO World podcast, Ian Bremmer interviews Noubar Afeyan, the co-founder of a leading vaccine developer Moderna. They'll discuss distribution plans, the revolutionary science behind Moderna's vaccine, and how a company younger than Twitter became a frontrunner in the race to end the pandemic.</p><p><em>Subscribe to the GZERO World Podcast on </em><a rel="noopener noreferrer" target="_blank" href="https://podcasts.apple.com/us/podcast/gzero-world-with-ian-bremmer/id1294461271"><em>Apple Podcasts</em></a><em>, </em><a rel="noopener noreferrer" target="_blank" href="https://open.spotify.com/show/13QW2sLPCjVbdDE6fmJCNf"><em>Spotify</em></a><em>, </em><a rel="noopener noreferrer" target="_blank" href="https://www.stitcher.com/show/gzero-world-with-ian-bremmer"><em>Stitcher</em></a><em>, or your preferred podcast platform to receive new episodes as soon as they're published.</em></p>]]></content:encoded>
</item>
<item>
<title>How the Moderna vaccine works, why it’s effective, and how it’ll be distributed</title>
<link>https://www.gzeromedia.com/video/gzero-world-clips/how-the-vaccine-works-why-its-effective-and-how-itll-be-distributed</link>
<guid isPermaLink="false">cmvrejmjyfzw207myo1w5tb00</guid>
<pubDate>Fri, 11 Dec 2020 01:18:42 +0000</pubDate>
<dc:creator>GZERO Staff</dc:creator>
<category>covid-19 vaccine</category>
<category>science-tech</category>
<category>ian bremmer</category>
<category>gzero world</category>
<category>covid-19</category>
<category>mrna</category>
<category>moderna</category>
<category>noubar afeyan</category>
<category>biotechnology</category>
<category>GZERO World Highlights</category>
<description>&quot;What we&apos;re trying to do is to educate the immune system to see the protein before it&apos;s seen the virus.&quot; In a race for a COVID vaccine, Moderna, a 10-year old company with no products previously on the market, developed a vaccine in 10 months, by using revolutionary new mRNA technology. Now the focus shifts to how to distribute and safely administer this vaccine. Moderna co-founder and chairman Noubar Afeyan explains. His conversation with Ian Bremmer was part of the latest episode of GZERO World, which began airing nationally in the US on public television Friday, December 11th. Check local listings.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrak4y77x4w07myiatbmnkj" type="image/jpeg" medium="image" width="1280" height="720">
<media:credit>youtu.be</media:credit>
<media:text>How the Moderna Vaccine Works, Why It’s Effective, and How It’ll Be Distributed | GZERO World</media:text>
</media:content>
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrak4y77x4w07myiatbmnkj" />
<content:encoded><![CDATA[<p>"What we're trying to do is to educate the immune system to see the protein before it's seen the virus." In a race for a COVID vaccine, Moderna, a 10-year old company with no products previously on the market, developed a vaccine in 10-months, by using revolutionary new mRNA technology. Now the focus shifts to how to distribute and safely administer this vaccine. Moderna co-founder and chairman Noubar Afeyan explains.</p><p>His conversation with Ian Bremmer was part of the latest episode of GZERO World, which began airing nationally in the US on public television Friday, December 11th. Check local listings.</p><p><em>Watch the GZERO World episode:&nbsp;</em><a href="https://www.gzeromedia.com/video/gzero-world-with-ian-bremmer/a-shot-in-the-arm-the-covid-19-vaccine-arrives"><strong>A Shot in the Arm: Moderna's Co-Founder on the COVID-19 Vaccine</strong></a></p>]]></content:encoded>
</item>
</channel>
</rss>